Authors
Jessica D Leuchter, Aisa M Moreno-Megui, Jamie R Odzer, Barbara J Coffey
Published in
Child and adolescent psychiatric clinics of North America. Volume 36. Issue 1. Pages 153-167. Epub Oct 14, 2026.
Abstract
Tic disorders arise from dysfunction within cortico-striato-thalamo-cortical circuits and are strongly linked to dopaminergic dysregulation. While Comprehensive Behavioral Intervention for Tics remains first-line treatment for functionally impairing tics, antipsychotics are among the most effective pharmacologic options for moderate to severe or refractory symptoms. Aripiprazole and risperidone have the strongest evidence base to date and are generally preferred because of their efficacy and tolerability. Emerging evidence from other medications impacting dopamine receptor function further supports dopamine signaling as a key therapeutic target in Tourette's disorder and other persistent tic disorders.
PMID:
43051730
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0